Back to
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
ARWR31 quarters
Position history for
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in ARROWHEAD PHARMACEUTICALS IN
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 964,479 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $78.6M as of 2026-Q2. The position was decreased (-27.5% shares). ARWR represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$78.6M
Current Shares
964,479
Total Value Change
+$77.9M
Total Shares Change
+909,215
Quarter-by-Quarter History
Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC